TRIUMF has announced a new research partnership with Ontario-based Fusion Pharmaceuticals to expand production and availability of actinium-225, a valuable but scarce radioisotope with tremendous promise as a cancer treatment.
Dr. Jess Brewer, a TRIUMF affiliate researcher and a member of the team that developed the laboratory’s Centre for Molecular and Material Sciences (CMMS), has been named a 2020 Fellow of the American Association for the Advancement of Science (AAAS)
TRIUMF is partnering with the British Columbia Institute of Technology (BCIT) to develop an enhanced and multi-faceted work-integrated learning (WIL) program to address the evolving needs of British Columbia’s economy.